Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation

Veterinary Medicine and Science

Scott S. Graves¹  Rainer Storb¹ 

[1] Clinical Research Division Fred Hutchinson Cancer Research Center Seattle Washington USA;

关键词: canine;    kidney;    lymphoma;    stem cell;    transplantation;   

DOI  :  10.1002/vms3.601

来源: DOAJ

【 摘 要 】

Abstract Pre‐clinical haematopoietic cell transplantation (HCT) studies in canines have proven to be invaluable for establishing HCT as a highly successful clinical option for the treatment of malignant and non‐malignant haematological diseases in humans. Additionally, studies in canines have shown that immune tolerance, established following HCT, enabled transplantation of solid organs without the need of lifelong immunosuppression. This progress has been possible due to multiple biological similarities between dog and mankind. In this review, the hurdles that were overcome and the methods that were developed in the dog HCT model which made HCT clinically possible are examined. The results of these studies justify the question whether HCT can be used in the veterinary clinical practice for more wide‐spread successful treatment of canine haematologic and non‐haematologic disorders and whether it is prudent to do so.

【 授权许可】

Unknown